Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 229Leukemia, Lymphocytic, Chronic, B-Cell 213Leukemia 203Myelodysplastic Syndromes 182Precursor Cell Lymphoblastic Leukemia-Lymphoma 174Lymphoma, Non-Hodgkin 121Lymphoma 120Hodgkin Disease 108Multiple Myeloma 107Lymphoma, Follicular 100Lymphoma, Mantle-Cell 99Lymphoma, Large B-Cell, Diffuse 86Lymphoma, B-Cell, Marginal Zone 85Congenital Abnormalities 85Myeloproliferative Disorders 84Burkitt Lymphoma 81Leukemia, Myelomonocytic, Chronic 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Leukemia, Myeloid, Chronic-Phase 74Leukemia, Myeloid, Accelerated Phase 73Lymphoma, Large-Cell, Immunoblastic 61Anemia, Refractory, with Excess of Blasts 60Blast Crisis 55Primary Myelofibrosis 53Waldenstrom Macroglobulinemia 52Neoplasms, Plasma Cell 52Recurrence 48Hematologic Neoplasms 45Dendritic Cell Sarcoma, Interdigitating 42Leukemia, Prolymphocytic 41

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 5Ciprofloxacin 4gamma-Globulins 3Caspofungin 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Voriconazole 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Levofloxacin 2Itraconazole 2Immunoglobulins, Intravenous 2Fluconazole 2talquetamab 1idecabtagene vicleucel 1gilteritinib 1fludarabine phosphate 1ethanolamine oleate 1drotrecogin alfa activated 1amphotericin B, deoxycholate drug combination 1X-Rays 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × fludarabine phosphate × Other hematologic neoplasm × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡